| Description | The LV0HV1 antibody, also known as humanized Lym2 antibody, is an anti-human CRTH2 antibody. It is designed to specifically bind to human CRTH2. LV0HV1 targets human CD4-positive T cells and is effective against a group of lymphocytes that are separated based on forward scatter (FSC) and side scatter (SSC) development. These lymphocytes are further fractionated based on CD3 and CD4 positive cells. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Human |
| Isotype | IgG1 |
| Expression Species | HEK293F or CHO cell line |
| Conjugation | Unconjugated |
| Purity | >95% |
| Endotoxin | <1 EU/mg |
| Form | Liquid |
| Purification | Protein A purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within one or two weeks. Store at -20°C for long term. Avoid repeated freeze/thaw cycles. Refer to the COA file for specifics. |
| Application | ELISA; FC; FuncS |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | PTGDR2 |
| Alternative Name | DP2; DL1R; CD294; CRTH2; GPR44; Lym2 LV0HV1; prostaglandin D2 receptor 2; G-protein coupled receptor 44; chemoattractant receptor homologous molecule expressed on T helper type 2 cells; chemoattractant receptor-homologous molecule expressed on TH2 cells; putative G-protein coupled receptor 44 |
| Gene ID | 11251 |
| UniProt | Q9Y5Y4 |
